<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: clinical data</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'clinical data'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22clinical+data%22&t=%22clinical+data%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:38:14 +0100</lastBuildDate>
        <item>
            <title>FDA Chemist Charged With Insider Trading</title>
            <link>http://www.medworm.com/index.php?rid=4653601&amp;cid=t_375275_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fd412WCNP6vY%2F</link>
            <description>An FDA chemist named Cheng Yi Liang was charged today by the US Securities and Exchange Commission with insider trading on confidential info about upcoming announcements of 27 different FDA approval decisions involving 19 publicly traded companies and generated more than $3.6 million in illegal profits for himself. And would you believe that he avoided incurring any losses? 
Some of the FDA announcements involved approval of new drugs while others concerned were negative decisions. In each instance, the SEC says he traded in the same direction as the announcement, but worked hard to disguise his work. Beginning in July 2006, Liang traded in seven brokerage accounts, including six listed in the names of other people, including his 25-year-old (who was also charged) and his 84-year-old mothe...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4653601</comments>
            <pubDate>Tue, 29 Mar 2011 20:46:19 +0100</pubDate>
            <guid isPermaLink="false">4653601</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=4507583&amp;cid=t_375275_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FV52maQaohbs%2F</link>
            <description>Hello, everyone, and nice to see you again. We hope you had a relaxing weekend and feel refreshed. Now, of course, the time has come to resume the routine of meetings and deadlines. To cope, we are reaching for the mandatory cup of stimulation and invite you to join us. Meanwhile, here are a few tidbits to get you started. Hope your day goes well and drop us a line if you hear something of interest&amp;#8230;
Forest Labs To Pay $1.2B For Clinical Data And An Antidepressant (Reuters)
Gilead To Buy Calistoga Pharma For $375M (Silicon Valley Business Journal)
Medtronic To Eliminate Up to 2,000 Jobs (Bloomberg News)
Elan Reports 10 More PML Cases With Tysabri (Irish Examiner)
Merck Vioxx Settlement Causes Money Fight Among Lawyers (Bloomberg News)
Sanofi Looks For Generics And OTC Brands In India ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4507583</comments>
            <pubDate>Tue, 22 Feb 2011 12:59:38 +0100</pubDate>
            <guid isPermaLink="false">4507583</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=4139480&amp;cid=t_375275_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FQQmWLy0WjS4%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Weill Cornell Medical College hired Steve Paul to head the Appel Institute for Alzheimer&amp;#8217;s Research. Before joining the institution, Paul was vp of science and technology and president of at Eli Lilly Research Labs and was the scientific ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4139480</comments>
            <pubDate>Fri, 05 Nov 2010 12:32:57 +0100</pubDate>
            <guid isPermaLink="false">4139480</guid>        </item>
        <item>
            <title>Bias In Clinical Research Is Inevitable</title>
            <link>http://www.medworm.com/index.php?rid=4027161&amp;cid=t_375275_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fbias-in-clinical-research-is-inevitable%2F2010.10.03</link>
            <description>DrRich has said many times that clinical science is among the least exact of the sciences, and therefore, the results of clinical research are particularly susceptible to “spinning” by various interested parties, in order to yield the kind of results they would prefer to see.
Until recent times in American medicine, the parties who have been most interested in spinning clinical research have been the people who run drug companies and medical device companies (who need clinical research which supports the use of their products), and the medical specialists (who are more likely to be paid for performing medical procedures that are supported by clinical research). In writing about such data-spinning abuses, DrRich has particularly targeted his own Cardiology Guild, but only because he kno...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4027161</comments>
            <pubDate>Sun, 03 Oct 2010 12:00:16 +0100</pubDate>
            <guid isPermaLink="false">4027161</guid>        </item>
        <item>
            <title>Low expectations for future of clinical data mining--a study</title>
            <link>http://www.medworm.com/index.php?rid=3672068&amp;cid=t_375275_155_f&amp;fid=38412&amp;url=http%3A%2F%2Fpathlabmed.typepad.com%2Fsurgical_pathology_and_la%2F2010%2F06%2Flow-expectations-for-future-of-clinical-data-mininga-study.html</link>
            <description>I picked this up from Fierce Health IT newsletter:
Anvita Health commissioned a newly released HIMSS Analytics study on clinical 
data mining. HIMSS Analytics convened a focus group of CMOs and and CMIOs of 
provider and payer organizations for the report.Payers and providers alike generally don&amp;#39;t often employ clinical data for 
real-time decision-making, in part because information is in so many disparate 
formats, some important data elements are missing and because they believe the 
costs generally outweigh the benefits. &amp;quot;These challenges are consistent with 
what we&amp;#39;ve seen and heard from our payer and provider customers,&amp;quot; Noffsinger 
explains. &amp;quot;Interoperability of data is a hurdle, but it&amp;#39;s not 
insurmountable.&amp;quot;&amp;quot;A key finding for us was that both p...</description>
            <author>The Daily Sign-Out</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3672068</comments>
            <pubDate>Wed, 16 Jun 2010 20:30:00 +0100</pubDate>
            <guid isPermaLink="false">3672068</guid>        </item>
        <item>
            <title>Real Participation in RHIO and HIE</title>
            <link>http://www.medworm.com/index.php?rid=3036990&amp;cid=t_375275_113_f&amp;fid=34634&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FEmrAndHipaa%2F%7E3%2FeXeiCoqQKS0%2F</link>
            <description>Everyone seems to love talking about RHIO, HIE and all of the other various initiatives happening around sharing patient health information amongst doctors. This weekend, I want to open it up to you the readers to get an idea of what type of participation you&amp;#8217;ve had in an RHIO, HIE or other clinical data exchange.
Are you participating in one now? Do you like it? Do you hate it? In fact, what do you like and what do you hate? Do you use an EMR to interface with the exchange? What&amp;#8217;s the interface like? How much work is it to manage the interface?
I&amp;#8217;d also be interested in hearing about people who are working through the process now. Where are you at in the process? What&amp;#8217;s holding you up from making this happen?
Let&amp;#8217;s help educate each other on what&amp;#8217;s happ...</description>
            <author>EMR and HIPAA</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3036990</comments>
            <pubDate>Sat, 28 Nov 2009 16:11:30 +0100</pubDate>
            <guid isPermaLink="false">3036990</guid>        </item>
    </channel>
</rss>

